Product
소개
ErbiBridge ELISA For Erbitux Biosimilar Comparison
Complete kit for the systematic 3-D conformational comparability analysis of
Erbitux biosimilar molecule to Cetuximab (Erbitux trade name)
Cetuximab is a chimeric (mouse/human) monoclonal antibody that inhibits epidermal growth factor receptor (EGFR). Cetuximab is manufactured by ImClone and Bristol-Myers Squibb and is given by IV infusion for the treatment of metastatic colorectal cancer and head and neck cancer.
This kit will allow for conformational comparison between Erbitux Biosimilars and authentic Cetuximab.
주문정보
AB000202 ErbiBridge ELISA (for Erbitux Biosimilar Comparison) 1 Kit
관련자료